A former executive at a drug maker is the new CEO of a contract manufacturer serving the pharmaceutical industry.
Grand River Aseptic Manufacturing in Grand Rapids, or GRAM, said last week that it has named Tom Ross to the role.
GRAM said Ross’s “experience, background and passion make him an excellent leader.”
Ross joined GRAM in January 2013 as an advisor and in August of that same year, he was named president of the company.
Before coming to GRAM, Ross spent a good part of his career at Perrigo, a generic drug maker in Allegan. He rose through the ranks and became “the top financial officer on the executive team.”
GRAM said that while Ross served in executive roles at Perrigo, the company grew from $300 million to $1 billion.
Ross eventually left Perrigo to start two successful companies.
He is a native of Michigan.
During his time at GRAM, Ross has been able to secure $10 million in investment, opened a finishing facility and grown the company from 25 employees to more than 70, according to Jerry Arthur, chairman, GRAM.
“Tom’s vision for GRAM is that the company be a high-growth industry leader in life sciences,” Arthur said.
He noted that vision is already underway, thanks to Ross’s “leadership, intellect and discipline.”
Ross said the company’s customers “depend on GRAM’s adherence to the strictest quality standards to produce safe and effective pharmaceuticals.”
Ross called it “satisfying to create a new leader in life sciences,” based in Grand Rapids.
GRAM was founded in 2010 and has become FDA approved as a parenteral sterile injectable pharmaceutical company.
The company specializes in pre-clinical, clinical and commercial manufacturing and offers various services: sterile product development and manufacture; lyophilization; terminal sterilization and analytical and microbiological testing; stability sample storage; labeling; packaging storage; and distribution.